
Ecliptic Capital is an Austin-based early-stage venture capital firm investing in scientific breakthroughs with real-world impact across climate and energy, life sciences and healthcare, and identity and security sectors.
Their most common stage is series-a (54% of deals). Average disclosed round size is $14.8M (across 8 rounds with reported amounts).
Portfolio
10
Fund Size
$125M
Top Stage
Series A
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
13 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Series A | $10M | Aug 2025 | |
| Series B | — | Apr 2023 | |
| Series B | $60M | Jan 2023 | |
| Series A | $24M | Jan 2023 | |
| Series A | $3M | Aug 2021 | |
| Seed | $1M | Aug 2021 | |
| Series A | — | Jun 2021 | |
| Series A | — | Jun 2021 | |
| Series A | $10M | Jan 2021 | |
| Seed | $4M | Jun 2018 | |
| Seed | $6M | — | |
| Series A | — | — | |
| Seed | — | — |
Top Co-Investors
Valor Equity Partners4 shared
Lightspeed Venture Partners2 shared
Trammell Venture Partners2 shared
Starting Line2 shared
Redpoint Ventures1 shared
Amplify Partners1 shared
Lux Capital1 shared
BoxGroup1 shared
Ruttenberg Gordon Investments1 shared
ITOCHU Corporation1 shared
CrowdStrike Falcon Fund1 shared
Alumni Ventures1 shared
Stone Ridge Holdings Group1 shared
GD11 shared
Hitachi Ventures1 shared
Undisclosed Angel Investors1 shared
Canaan Partners1 shared
Novo Capital1 shared
Last updated: 20 October 2026